Titan Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.02.19	AVEO Crashes, FDA Approves 1st Generic Of ADVAIR DISKUS, 'Tis Advantage TTNP (RTTNews)
12.11.18	Ausblick: Titan Pharmaceuticals gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
03.07.18	FDA Nod For ALKS, TRXC Sees 4-fold Increase In Q2 Revenue, BCLI On Watch (RTTNews)
30.05.18	Titan Pharmaceuticals And Braeburn Announce Mutual Termination Of License Agreement For Probuphine® For Opioid Dependence (PR Newswire)
16.05.18	LLY Gets Headache Relief, XENE Abuzz, 3rd Time's A Charm For PFE's Epogen Biosim (RTTNews)
15.05.18	Titan Pharmaceuticals Reports First Quarter 2018 Financial Results (PR Newswire)
14.05.18	Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board (PR Newswire)
08.05.18	Titan Pharmaceuticals To Report First Quarter 2018 Financial Results On May 15, 2018 (PR Newswire)
02.04.18	Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results (PR Newswire)
26.03.18	Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2017 Financial Results (PR Newswire)
23.03.18	OMER Back In Focus, INNT Moving Ahead, Keep An Eye On EARS (RTTNews)
21.03.18	Titan Executes Agreement For Acquisition By Molteni Of Probuphine® In Europe And Other Select Territories (PR Newswire)
02.02.18	Titan Announces Amendment To Horizon Loan Agreement (PR Newswire)
22.01.18	Titan In Discussions With Braeburn Regarding U.S. Probuphine® Commercialization (PR Newswire)
28.11.17	Titan Pharmaceuticals Partners With Molteni To Market Probuphine® In Europe (PR Newswire)
27.11.17	European Medicines Agency Accepts Titan Pharmaceuticals' Marketing Authorization Application For Probuphine® (PR Newswire)
09.11.17	Titan Pharmaceuticals Reports Third Quarter 2017 Financial Results (PR Newswire)
03.11.17	Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2017 Financial Results (PR Newswire)
19.10.17	Titan Pharmaceuticals Presents Non-Clinical Data From Liothyronine (L-T3) Implant Studies (PR Newswire)
11.10.17	First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease (PR Newswire)
02.10.17	Titan Pharmaceuticals and Opiant Pharmaceuticals Collaborate to Explore a New Approach to Opioid Use Disorder Treatment (PR Newswire)
20.09.17	Titan Pharmaceuticals To Present At Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
12.09.17	Mintigo Joins Marketo Accelerate as an Inaugural Partner (PR Newswire)
25.08.17	ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB's Humira Biosim (RTTNews)
24.08.17	Titan Pharmaceuticals Receives FDA Clearance To Begin Clinical Study Of Parkinson's Disease Treatment (PR Newswire)
09.08.17	Titan Pharmaceuticals Reports Second Quarter 2017 Financial Results (PR Newswire)
02.08.17	Titan Pharmaceuticals Schedules Conference Call To Review Second Quarter 2017 Financial Results (PR Newswire)
27.07.17	Titan Pharmaceuticals Secures $10 Million Debt Facility From Horizon Technology Finance (PR Newswire)
06.07.17	Titan Pharmaceuticals and Walter Reed Army Institute of Research Collaborate to Evaluate ProNeura Antimalarial Implants (PR Newswire)
29.06.17	Fortune Article Highlights Titan Pharmaceuticals And Its ProNeura Technology (PR Newswire)
18.05.17	Gainers & Losers Of May 17: SNDX, PULM, PBYI, CNCE, XLRN... (RTTNews)
17.05.17	Gainers & Losers Of May 16: AKBA, MTFB, TTNP, IMUC, CAPR... (RTTNews)
04.05.17	Titan Pharmaceuticals Schedules Conference Call To Review First Quarter 2017 Financial Results (PR Newswire)
16.03.17	Titan Pharmaceuticals Reports Full Year And Fourth Quarter 2016 Financial Results (PR Newswire)
10.03.17	Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2016 Financial Results (PR Newswire)
07.03.17	Titan Pharmaceuticals To Present At 29th Annual ROTH Conference (PR Newswire)
27.02.17	Titan Pharmaceuticals Receives FDA Communication On Ropinirole Implant Investigational New Drug Application (PR Newswire)
13.02.17	Fast Company Honors Braeburn Pharmaceuticals as a Top Ten Most Innovative Company in Biotech (PR Newswire)
13.01.17	Braeburn Pharmaceuticals' Probuphine® Implant Receives J-Code by Centers for Medicare & Medicaid Services (PR Newswire)
04.01.17	Titan Pharmaceuticals Appoints Two New Board Members (PR Newswire)
21.11.16	Braeburn Pharmaceuticals and CEO Behshad Sheldon Win Stevie Awards for Best New Product or Service and Female Executive of the Year (PR Newswire)
27.05.16	TTNP On A High, Double Blessing For NERV, AVIR In Trouble, SAGE Awaits Data (RTTNews)
27.05.16	Titan Pharma Says FDA Approves Probuphine To Treat Opioid Dependence; Stock Up (RTTNews)
01.05.16	Biotech Stocks Facing FDA Decision In May (RTTNews)
22.02.16	FDA Expands Use Of Pfizer's Ibrance, Attack On Titan, Spectrum Gets FDA Date (RTTNews)
13.01.16	Titan, Braeburn Announce FDA Advisory Committee Votes In Favor Of Probuphine (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Titan Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten